OBJECTIVE: To investigate the CYP1A2 phenotype distribution in a population with an increased exposure to polychlorinated biphenyls (PCBs) that would likely induce an increased activity of this enzyme. Further, to investigate the effect of sex, smoking, and oral contraceptive use on the CYP1A2 activity. METHODS: In 305 randomly selected Faroese residents aged 18-60 years, the CYP1A2 activity was determined following oral intake of a caffeine dose and subsequent determination of the urinary metabolites and calculation of the caffeine metabolic ratio (CMR). PCB exposure was assessed by measuring the serum concentration of major congeners. RESULTS: The CYP1A2 phenotype distribution was unimodal. The CMR was significantly higher both in smoking men and in smoking women, independent of oral contraceptive use, as compared with non-smokers. Among non-smokers, the CMR was significantly higher in women not using oral contraceptives than in those using oral contraceptives; a similar difference could not be established among smokers. The CMR appeared higher in men than in women, but stratified analyses confirmed a significant sex-related difference only among smokers not using oral contraceptives. Overall, the mean CMR in Faroese was significantly higher compared with the mean CMR in Danish historical controls. No association was found with PCB exposure and individual PCB congeners, except for one of three dioxin-like congeners, in confounder-adjusted multiple regression analyses. CONCLUSION: The CYP1A2 phenotype in Faroese residents was unimodally distributed and showed the inducing effect of smoking and the inhibiting effect of use of oral contraceptives, but a sex-related difference was not apparent after confounder adjustment. There was no statistically significant association between CMR and PCB exposure.
OBJECTIVE: To investigate the CYP1A2 phenotype distribution in a population with an increased exposure to polychlorinated biphenyls (PCBs) that would likely induce an increased activity of this enzyme. Further, to investigate the effect of sex, smoking, and oral contraceptive use on the CYP1A2 activity. METHODS: In 305 randomly selected Faroese residents aged 18-60 years, the CYP1A2 activity was determined following oral intake of a caffeine dose and subsequent determination of the urinary metabolites and calculation of the caffeine metabolic ratio (CMR). PCB exposure was assessed by measuring the serum concentration of major congeners. RESULTS: The CYP1A2 phenotype distribution was unimodal. The CMR was significantly higher both in smoking men and in smoking women, independent of oral contraceptive use, as compared with non-smokers. Among non-smokers, the CMR was significantly higher in women not using oral contraceptives than in those using oral contraceptives; a similar difference could not be established among smokers. The CMR appeared higher in men than in women, but stratified analyses confirmed a significant sex-related difference only among smokers not using oral contraceptives. Overall, the mean CMR in Faroese was significantly higher compared with the mean CMR in Danish historical controls. No association was found with PCB exposure and individual PCB congeners, except for one of three dioxin-like congeners, in confounder-adjusted multiple regression analyses. CONCLUSION: The CYP1A2 phenotype in Faroese residents was unimodally distributed and showed the inducing effect of smoking and the inhibiting effect of use of oral contraceptives, but a sex-related difference was not apparent after confounder adjustment. There was no statistically significant association between CMR and PCB exposure.
Authors: P Grandjean; P Weihe; V W Burse; L L Needham; E Storr-Hansen; B Heinzow; F Debes; K Murata; H Simonsen; P Ellefsen; E Budtz-Jørgensen; N Keiding; R F White Journal: Neurotoxicol Teratol Date: 2001 Jul-Aug Impact factor: 3.763
Authors: G H Lambert; D A Schoeller; H E Humphrey; A N Kotake; H Lietz; M Campbell; W Kalow; S P Spielberg; M Budd Journal: Environ Health Perspect Date: 1990-11 Impact factor: 9.031
Authors: Jennifer J Schlezinger; Pamela L Bernard; Amelia Haas; Philippe Grandjean; Pal Weihe; David H Sherr Journal: Environ Health Perspect Date: 2010-05 Impact factor: 9.031
Authors: L Kvist; A Giwercman; P Weihe; T Kold Jensen; P Grandjean; J Halling; M Skaalum Petersen; Y Lundberg Giwercman Journal: Environ Int Date: 2014-09-16 Impact factor: 9.621
Authors: Clara Amalie Gade Timmermann; Henning Sloth Pedersen; Esben Budtz-Jørgensen; Peter Bjerregaard; Youssef Oulhote; Pál Weihe; Flemming Nielsen; Philippe Grandjean Journal: Int J Circumpolar Health Date: 2019-12 Impact factor: 1.228
Authors: Melissa J Perry; Heather A Young; Philippe Grandjean; Jónrit Halling; Maria Skaalum Petersen; Sheena E Martenies; Parisa Karimi; Pál Weihe Journal: Environ Health Perspect Date: 2015-11-04 Impact factor: 9.031
Authors: Clara Amalie Gade Timmermann; Anna L Choi; Maria Skaalum Petersen; Flemming Nielsen; Esben Budtz-Jørgensen; Pál Weihe; Philippe Grandjean Journal: Int J Circumpolar Health Date: 2017 Impact factor: 1.228
Authors: Maria Skaalum Petersen; Jónrit Halling; Niels Jørgensen; Flemming Nielsen; Philippe Grandjean; Tina Kold Jensen; Pál Weihe Journal: Int J Environ Res Public Health Date: 2018-08-30 Impact factor: 3.390